Works by Benter, Ibrahim F.
Results: 31
Chronic Treatment with Ang-(1-7) Reverses Abnormal Reactivity in the Corpus Cavernosum and Normalizes Diabetes-Induced Changes in the Protein Levels of ACE, ACE2, ROCK1, ROCK2 and Omega-Hydroxylase in a Rat Model of Type 1 Diabetes.
- Published in:
- Journal of Diabetes Research, 2014, p. 1, doi. 10.1155/2014/142154
- By:
- Publication type:
- Article
RU28318, an Aldosterone Antagonist, in Combination with an ACE Inhibitor and Angiotensin Receptor Blocker Attenuates Cardiac Dysfunction in Diabetes.
- Published in:
- Journal of Diabetes Research, 2013, p. 1, doi. 10.1155/2013/427693
- By:
- Publication type:
- Article
FPTIII Mitigates Peroxisome-Mediated Oxidative Stress in Kidneys of Spontaneously Hypertensive Diabetic Rats.
- Published in:
- Kidney & Blood Pressure Research, 2010, v. 33, n. 1, p. 60, doi. 10.1159/000289574
- By:
- Publication type:
- Article
Ang-(1-7)/ MAS1 receptor axis inhibits allergic airway inflammation via blockade of Src-mediated EGFR transactivation in a murine model of asthma.
- Published in:
- PLoS ONE, 2019, v. 14, n. 11, p. 1, doi. 10.1371/journal.pone.0224163
- By:
- Publication type:
- Article
The effect of cardiac ischemic preconditioning on rat left ventricular gene expression profile.
- Published in:
- FASEB Journal, 2007, v. 21, n. 5, p. A419
- By:
- Publication type:
- Article
Targeting the epidermal growth factor receptor (EGFR/ErbB) for the potential treatment of renal pathologies.
- Published in:
- Frontiers in Pharmacology, 2024, p. 01, doi. 10.3389/fphar.2024.1394997
- By:
- Publication type:
- Article
Angiotensin-(1-7) prevents activation of NADPH oxidase and renal vascular dysfunction in diabetic hypertensive rats.
- Published in:
- 2008
- By:
- Publication type:
- journal article
Pharmacotherapy in COVID-19 patients: a review of ACE2-raising drugs and their clinical safety.
- Published in:
- Journal of Drug Targeting, 2020, v. 28, n. 7/8, p. 683, doi. 10.1080/1061186X.2020.1797754
- By:
- Publication type:
- Article
The dual targeting of EGFR and ErbB2 with the inhibitor Lapatinib corrects high glucose-induced apoptosis and vascular dysfunction by opposing multiple diabetes-induced signaling changes.
- Published in:
- Journal of Drug Targeting, 2015, v. 23, n. 6, p. 506, doi. 10.3109/1061186X.2015.1057150
- By:
- Publication type:
- Article
Toxicogenomics of drug delivery systems: Exploiting delivery system-induced changes in target gene expression to enhance siRNA activity.
- Published in:
- Journal of Drug Targeting, 2007, v. 15, n. 1, p. 83, doi. 10.1080/10611860601151860
- By:
- Publication type:
- Article
Sustained Polymeric Delivery of Gene Silencing Antisense ODNs, siRNA, DNAzymes and Ribozymes: In Vitro and In Vivo Studies.
- Published in:
- Journal of Drug Targeting, 2004, v. 12, n. 6, p. 393, doi. 10.1080/10611860400003858
- By:
- Publication type:
- Article
Toxicogenomics of Non-viral Vectors for Gene Therapy: A Microarray Study of Lipofectin- and Oligofectamine-induced Gene Expression Changes in Human Epithelial Cells.
- Published in:
- Journal of Drug Targeting, 2003, v. 11, n. 6, p. 311, doi. 10.1080/10611860310001636908
- By:
- Publication type:
- Article
Role of epidermal growth factor receptor (EGFR) in corneal remodelling in diabetes.
- Published in:
- Acta Ophthalmologica (1755375X), 2009, v. 87, n. 8, p. 881, doi. 10.1111/j.1755-3768.2008.01434.x
- By:
- Publication type:
- Article
Transactivation of ErbB Family of Receptor Tyrosine Kinases Is Inhibited by Angiotensin-(1-7) via Its Mas Receptor.
- Published in:
- PLoS ONE, 2015, v. 10, n. 10, p. 1, doi. 10.1371/journal.pone.0141657
- By:
- Publication type:
- Article
Cationic Polyamidoamine Dendrimers as Modulators of EGFR Signaling In Vitro and In Vivo.
- Published in:
- PLoS ONE, 2015, v. 10, n. 7, p. 1, doi. 10.1371/journal.pone.0132215
- By:
- Publication type:
- Article
Diabetes-Induced Renal Vascular Dysfunction Is Normalized by Inhibition of Epidermal Growth Factor Receptor Tyrosine Kinase.
- Published in:
- Journal of Vascular Research, 2005, v. 42, n. 4, p. 284, doi. 10.1159/000085904
- By:
- Publication type:
- Article
Role of Ca<sup>2+</sup>/calmodulin-dependent protein kinase II in development of vascular dysfunction in diabetic rats with hypertension.
- Published in:
- Cell Biochemistry & Function, 2008, v. 26, n. 2, p. 256, doi. 10.1002/cbf.1446
- By:
- Publication type:
- Article
Cardioprotection from ischemia-reperfusion injury due to Ras-GTPase inhibition is attenuated by glibenclamide in the globally ischemic heart.
- Published in:
- Cell Biochemistry & Function, 2007, v. 25, n. 4, p. 455, doi. 10.1002/cbf.1353
- By:
- Publication type:
- Article
Phosphoinositide 3-kinase mediated signalling contributes to development of diabetes-induced abnormal vascular reactivity of rat carotid artery.
- Published in:
- Cell Biochemistry & Function, 2006, v. 24, n. 1, p. 13, doi. 10.1002/cbf.1278
- By:
- Publication type:
- Article
Angiotensin-(1-7) Downregulates Diabetes-Induced cGMP Phosphodiesterase Activation in Rat Corpus Cavernosum.
- Published in:
- BioMed Research International, 2017, v. 2017, p. 1, doi. 10.1155/2017/5084961
- By:
- Publication type:
- Article
Mitigating Cardiotoxicity of Dendrimers: Angiotensin-(1-7) via Its Mas Receptor Ameliorates PAMAM-Induced Cardiac Dysfunction in the Isolated Mammalian Heart.
- Published in:
- Pharmaceutics, 2022, v. 14, n. 12, p. 2673, doi. 10.3390/pharmaceutics14122673
- By:
- Publication type:
- Article
Role of 20-Hydroxyeicosatetraenoic and Epoxyeicosatrienoic Acids in the Regulation of Vascular Function in a Model of Hypertension and Endothelial Dysfunction.
- Published in:
- Pharmacology, 2010, v. 86, n. 3, p. 149, doi. 10.1159/000317521
- By:
- Publication type:
- Article
Angiotensin-(1-7) inhibits allergic inflammation, via the MAS1 receptor, through suppression of ERK1/2- and NF-κB-dependent pathways.
- Published in:
- 2012
- By:
- Publication type:
- journal article
Angiotensin-(1-7) inhibits allergic inflammation, via the MAS1 receptor, through suppression of ERK1/2- and NF-κB-dependent pathways.
- Published in:
- British Journal of Pharmacology, 2012, v. 166, n. 6, p. 1964, doi. 10.1111/j.1476-5381.2012.01905.x
- By:
- Publication type:
- Article
Angiotensin-(1-7) inhibits epidermal growth factor receptor transactivation via a Mas receptor-dependent pathway.
- Published in:
- British Journal of Pharmacology, 2012, v. 165, n. 5, p. 1390, doi. 10.1111/j.1476-5381.2011.01613.x
- By:
- Publication type:
- Article
Nanotoxicology of Dendrimers in the Mammalian Heart: ex vivo and in vivo Administration of G6 PAMAM Nanoparticles Impairs Recovery of Cardiac Function Following Ischemia-Reperfusion Injury.
- Published in:
- International Journal of Nanomedicine, 2020, v. 15, p. 4393, doi. 10.2147/IJN.S255202
- By:
- Publication type:
- Article
Nonviral delivery of synthetic siRNAs in vivo.
- Published in:
- Journal of Clinical Investigation, 2007, v. 117, n. 12, p. 3623, doi. 10.1172/JCI33494
- By:
- Publication type:
- Article
Epidermal growth factor receptor tyrosine kinase-mediated signalling contributes to diabetes-induced vascular dysfunction in the mesenteric bed.
- Published in:
- British Journal of Pharmacology, 2005, v. 145, n. 6, p. 829, doi. 10.1038/sj.bjp.0706238
- By:
- Publication type:
- Article
The Role of Epidermal Growth Factor Receptor Family of Receptor Tyrosine Kinases in Mediating Diabetes-Induced Cardiovascular Complications.
- Published in:
- Frontiers in Pharmacology, 2021, v. 12, p. 1, doi. 10.3389/fphar.2021.701390
- By:
- Publication type:
- Article
Activation of ErbB2 and Downstream Signalling via Rho Kinases and ERK1/2 Contributes to Diabetes-Induced Vascular Dysfunction.
- Published in:
- PLoS ONE, 2013, v. 8, n. 6, p. 1, doi. 10.1371/journal.pone.0067813
- By:
- Publication type:
- Article
Activation of EGFR/ERBB2 via Pathways Involving ERK1/2, P38 MAPK, AKT and FOXO Enhances Recovery of Diabetic Hearts from Ischemia-Reperfusion Injury.
- Published in:
- PLoS ONE, 2012, v. 7, n. 6, p. 1, doi. 10.1371/journal.pone.0039066
- By:
- Publication type:
- Article